U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493070) titled 'Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca' on March 20.
Brief Summary: Background: In the treatment of liver cancer, TACE (transarterial chemoembolization) combined with ablation is commonly used. The chemotherapeutic drug iodized oil emulsion prepared by the ultra-stable homogeneous mixture formulation technology (SHIFT) is stable, efficient, and has low toxicity. However, its effectiveness has not been verified in the post-TACE thermal ablation treatment. Objective: To evaluate the efficacy and safety of the ultra-stable homogeneous iodized oil-chemotherapy drug formulation in the treatmen...